Background: The performance of small diameter implantable cardioverter defibrillator (ICD) leads is questionable. However, data on performance during long-term follow-up are scarce. The aim of this study is to provide an update for the lead failure and cardiac perforation rate of Medtronic's Sprint Fidelis ICD lead (Medtronic Inc., Minneapolis, MN, USA) and St. Jude Medical's Riata ICD lead (St. Jude Medical Inc., St. Paul, MN, USA).
Methods: Since 1996, all ICD system implantations at the Leiden University Medical Center, the Netherlands, are registered. For this study, data up to February 2011 on 396 Sprint Fidelis leads (follow-up 3.4 ± 1.5 years), 165 8-French (F) Riata leads (follow-up 4.6 ± 2.6 years), and 30 7-F Riata leads (follow-up 2.9 ± 1.3 years) were compared with a benchmark cohort of 1,602 ICD leads (follow-up 3.4 ± 2.7 years) and assessed for the occurrence of lead failure and cardiac perforation.
Results: During follow-up, the yearly lead failure rate of the Sprint Fidelis lead, 7-F Riata lead, 8-F Riata lead, and the benchmark cohort was 3.54%, 2.28%, 0.78%, and 1.14%, respectively. In comparison to the benchmark cohort, the adjusted hazard ratio of lead failure was 3.7 (95% confidence interval [CI] 2.4-5.7, P < 0.001) for the Sprint Fidelis lead and 4.2 (95% CI 1.0-18.0, P < 0.05) for the 7-F Riata lead. One cardiac perforation was observed (3.3%) in the 7-F Riata group versus none in the 8-F Riata and Sprint Fidelis lead population.
Conclusion: The current update demonstrates that the risk of lead failure during long-term follow-up is significantly increased for both the Sprint Fidelis and the 7-F Riata lead in comparison to the benchmark cohort. Only one cardiac perforation occurred.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1540-8159.2011.03338.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The axillary vein puncture for implantable cardiac defibrillator implantation: 14 years of experience. Analysis of the results.
Int J Cardiol
July 2024
Division of Cardiology, University of Verona, Verona, Italy.
Background: Axillary vein puncture (AVP) is a valid alternative to Subclavan vein puncture for leads insertion in cardiac implantable electronic device implantation, that may reduce acute and delayed complications. Very few data are available about ICD recipients. A simplified AVP technique is described.
View Article and Find Full Text PDFPoorer outcomes associated with more invasive lead management strategies for Abbott Riata leads: a large, multicenter experience.
J Interv Card Electrophysiol
August 2024
Cardiac Electrophysiology Laboratories, Kansas City Heart Rhythm Institute, University of Missouri-Columbia, 5100 W 110Th St., Ste 200, Overland Park, KS, 66211, USA.
Background: Over 100,000 Abbott Riata were implanted in the United States before they were recalled in 2010. There are still a significant number of Abbott Riata leads in use, and it is unclear how these leads should be managed at the time of generator change or lead malfunction. Although data comparing both Sprint Fidelis and Abbott Riata leads in this setting is available, there are no multicenter comparative studies of outcomes for various lead management strategies, including lead extraction (LE), lead abandonment/revision (LA), and generator change (GC) only at the time of device at elective replacement interval (ERI) for Abbott Riata leads.
View Article and Find Full Text PDFImpact of fracture-prone implantable cardioverter defibrillator leads on long-term patient mortality.
J Arrhythm
June 2023
Department of Cardiology Tokyo Women's Medical University 8-1 Kawada-cho, Shinjuku-ku Tokyo 162-8666 Japan.
Article Synopsis
- The study analyzed 445 Japanese patients with implantable cardioverter-defibrillator (ICD) leads to investigate the relationship between fracture-prone leads and patient outcomes.
- During an average follow-up period of 8.6 years, the study found that patients with advisory/Linox leads had a significantly higher risk of lead failure compared to those with non-advisory leads, although overall mortality rates were similar between the two groups.
- The findings suggest that while fracture-prone ICD leads warrant closer monitoring for failures, they do not negatively impact long-term survival rates in the studied population.
Comparative outcomes of Riata and Fidelis lead management strategies: Results from the NCDR-ICD Registry.
Pacing Clin Electrophysiol
November 2021
Division of Cardiology, Section of Electrophysiology, University of Washington, Seattle, Washington, USA.
Background: The Medtronic Sprint Fidelis® and Abbott Riata®/Riata ST® leads are at risk of failure and are subject to FDA recall. Comparative risks of various lead management strategies during elective generator change in a multi-center population are unknown. We aim to describe patients with functional, recalled ICD leads undergoing elective generator replacement and report outcomes according to lead management strategies.
View Article and Find Full Text PDFIn vitro modeling accurately predicts cardiac lead fracture at 10 years.
Heart Rhythm
September 2021
Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
Background: Development of a cardiac lead fracture model has the potential to differentiate well-performing lead designs from poor performing ones and could aid in future lead development.
Objective: The purpose of this study was to demonstrate a predictive model for lead fracture and validate the results generated by the model by comparing them to observed 10-year implantable cardioverter-defibrillator lead fracture-free survival.
Methods: The model presented here uses a combination of in vivo patient data, in vitro conductor fatigue test data, and statistical simulation to predict the fracture-free survival of cardiac leads.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!